TIAN CHANG GP (02182) Establishes Integrated Advanced Manufacturing Platform as Core Long-Term Strategy

Stock News
08/12

TIAN CHANG GP (02182) has announced that its board aims to further clarify the company's long-term strategic direction, centering on an "Integrated Advanced Manufacturing Platform." This move comes as the group continues to enhance its capabilities in advanced materials, precision manufacturing, and new product applications.

Over the years, the company has steadily developed core competencies spanning product design and engineering development, precision mold design and fabrication, precision injection molding, surface treatment and coloration, material and surface processing technologies, automated assembly, process engineering, and manufacturing services. This has led to the creation of a comprehensive manufacturing system that covers everything from product development to mass production.

In the field of precision mold design and manufacturing, TIAN CHANG GP has accumulated substantial technical expertise. Its precision molds and injection molding capabilities meet the H-level requirements for high-precision plastic molded parts under the GB/T 47067-2026 standard for "Plastic Moulded Parts - Tolerances and Acceptance Conditions." Leveraging this engineering and manufacturing foundation, the group has long provided services to global brand clients, covering engineering development, mold design, precision manufacturing, and mass production.

The board believes the group's core competitiveness does not rely on any single product or industry. Instead, it stems from its ability to integrate engineering, manufacturing, and mass production capacities, applying them flexibly according to different customer needs and product requirements. Based on this technical and manufacturing base, the company has formally adopted the "Integrated Advanced Manufacturing Platform" as its long-term positioning.

TIAN CHANG GP plans to continue advancing its engineering technology and advanced material capabilities while expanding cross-industry applications. The goal is to gradually build a more balanced and diversified business portfolio, thereby enhancing overall business resilience and long-term competitiveness. The company's existing engineering and manufacturing capabilities are already applied across multiple product areas, including consumer electronics, office furniture, telecommunications products, automotive products, solar energy systems, and other categories.

As a technological extension of its integrated platform, TIAN CHANG GP is developing new capabilities in semi-solid magnesium alloy injection molding (Magnesium Thixomolding). This initiative aims to further expand its advanced materials and lightweight manufacturing capabilities. To support the development of its integrated platform, particularly the semi-solid magnesium alloy injection molding segment, the group is establishing a new manufacturing facility in Huizhou City, Guangdong Province, China.

The board believes that continuously strengthening the group's core manufacturing capabilities, technology platforms, and cross-industry applications will help enhance its long-term competitiveness and business resilience. This strategy is expected to build a more solid and sustainable development foundation, ultimately creating long-term value for shareholders.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10